Advisory Research’s Bausch Health BHC Stock Holding History

Advisory Research’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-8,519	Closed	-$255K	–	288
2019 Q4	$255K	Buy	+8,519	New	+$221K	0.01%	294

Other funds holding BHC

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Advisory Research's BHC Position: Q1 2020 in Review

Advisory Research sold out of Bausch Health (BHC) in Q1 2020, closing a stake of 8,519 shares — an estimated $255K sold.

Advisory Research first reported a position in BHC in Q4 2019 and held it in 1 quarter. The position peaked at $255K in Q4 2019. 312 funds tracked by Wall St. Rank hold BHC as of Q1 2020.

Advisory Research reported no remaining Bausch Health position as of Q1 2020 after selling out during the quarter.
Advisory Research sold 8,519 Bausch Health shares in Q1 2020, an estimated $255K.
Advisory Research first reported a position in Bausch Health in Q4 2019 and held it in 1 quarter.
Advisory Research's Bausch Health position peaked at $255K in Q4 2019.
312 funds tracked by Wall St. Rank held Bausch Health as of Q1 2020.

Based on Advisory Research's 13F filing for Q1 2020, filed 12 May 2020.